Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Aqua Bio Technology Share Issue/Capital Change 2026

Feb 27, 2026

3535_rns_2026-02-27_aeb1a5e3-66eb-41e5-9777-92b8c5f13796.pdf

Share Issue/Capital Change

Open in viewer

Opens in your device viewer

abt
AQUA BIO TECHNOLOGY ASA
Press Release
27 February 2026 07:40:00 CET

Aqua Bio Technology ASA: Ex. share consolidation and change of ISIN today

Reference is made to the key information notice on 25 February 2026 published by Aqua Bio Technology ASA (the "Company"). The shares of the Company are trading exclusive the share consolidation (reverse share split) as of today, as described below.

Issuer name: Aqua Bio Technology ASA
Ex-date: 27 February 2026
Type of corporate action: Share consolidation (reverse share split)
Reverse split ratio: 50:1, i.e. fifty (50) old shares give one (1) new share.

Other information: Following completion of the share consolidation, the new number of issued shares of the Company will be 3,227,935 shares, each with a par value of NOK 5.00.

New ISIN: NO 001 3735894

Contacts
Kristian Flaten
CEO & CFO
Aqua Bio Technology ASA
Phone: +47 9509 2322
Email: [email protected]

About Us

Aqua Bio Technology ASA (ABTEC) is a technology and distribution group in skincare and nonfood. The group has distribution towards B2C and B2B, and offers freight, customs, and logistics services. The group also develops sustainable biotechnology for use in skincare products. Aqua Bio Technology is listed on Euronext Expand Oslo.

This notice is published by Kristian Flaten on the listed date and time.

This information has been submitted pursuant to the Securities Trading Act § 5-12 and MAR Article 17. The information was submitted for publication, through the agency of the contact persons set out above, at 2026-02-27 07:40 CET.

Aqua Bio Technology • Fornebuveien 37 • N-1366 Lysaker